Status:
UNKNOWN
Diabetes Mellitus and Inflammatory Bowel Disease
Lead Sponsor:
Assiut University
Conditions:
Inflammatory Bowel Diseases
Eligibility:
All Genders
Brief Summary
Diabetes mellitus is a hyperglycemic metabolic disorder due to insulin deficiency or resistance at its receptors, leads to impaired glucose metabolism and multi-organ affection; (optic, peripheral neu...
Detailed Description
Inflammatory bowel disease; (Crohn's disease and ulcerative colitis), is chronic relapsing inflammation in the gastrointestinal tract due to complex interactions among genetic, environmental, gut micr...
Eligibility Criteria
Inclusion
- \- All patients with IBD admitted at EL-Raghy Assiut university hospital in the period of first of October 2019 to the end of September 2020 The diagnosis of DM is confirmed by high random blood glucose level more than 200mg/dl three times per day or high HbA1c more than 6.5%.
- The diagnosis of IBD is confirmed by colonic biopsy results after colonoscopy.
Exclusion
- Patients didn't do colonoscopy or didn't get biopsy or with normal colonoscopy and biopsy
Key Trial Info
Start Date :
October 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04105348
Start Date
October 1 2019
End Date
October 1 2021
Last Update
October 1 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.